Abstract:A tri-block coupling-polymer composed of 4,4'-methylenediphenyl diisocyanate and poly (ethylene oxide) (PEO), abbreviated MPEO, was used as the template surface-modifying additive (SMA), based on which selected amino acids (lysine, arginine, glycin, and aspartic acid) and RGD peptide were respectively conjugated as functional endgroups of the PEO spacer-arms through sulfonyl chloride-activation routes. After the immobilization of biofunctional factors, the SMA-MPEO derivatives were noncovalently introduced onto the biomedical poly(ether urethane) (PEU) surfaces by physical blending methods. The SMA synthesis and PEU surface modification were monitored and analyzed by nuclear magnetic resonance spectroscopy, attenuated total reflection-infrared spectroscopy, and X-ray photoelectron spectroscopy. The human umbilical vein endothelial cells (HUVECs) were collected and harvested manually by collagenase digestion. The cell culture was performed respectively on the MPEO derivative-modified PEU surfaces and also on the surfaces of the commercially available polystyrene cell-culture plates (TCPS) for control. The cell adhesion rates and cell proliferation rates of the in vitro cultivated HUVEC were measured using flow cytometry. The individual cell viability rates were determined with MTT assay. The cell morphologies of the living HUVECs were investigated by optical inverted microscopy, and more detailed information was acquired from scanning electrical microscopy. The results indicated that the efficacy of SMA functional endgroups was the dominant factor for HUVEC compatibility; the proper-sized PEO spacers (M(w) 2 k) could support and mobilize the functional endgroups, optimizing the surface (interface) environment for the cell growth. As the endgroups of the SMA-MPEO derivatives and the bio-functional factors, the basic amino acids (lysine and arginine) demonstrated similar performances to that of the widely acknowledged cell growth-promoter, RGD peptide, which were superior to TCPS. Therefore, these MPEO derivative-modified PEU materials are promising to serve as novel polymeric permanent implants or interventional devices for cardiovascular biomedical applications.

In Situ Immobilization of Proteins and Rgd Peptide on Polyurethane Surfaces Via Poly(Ethylene Oxide) Coupling Polymers for Human Endothelial Cell Growth

Novel Human Endothelial Cell-Engineered Polyurethane Biomaterials for Cardiovascular Biomedical Applications.

Surface modification of poly(ether urethane) membrane with RGD and its cytocompatibility of human endothelial cell

Surface Immobilization of Bioactive Molecules on Polyurethane for Promotion of Cytocompatibility to Human Endothelial Cells

Peptide Immobilization on Polyethylene Terephthalate Surfaces to Study Specific Endothelial Cell Adhesion, Spreading and Migration.

Surface Patterning and Modification of Polyurethane Biomaterials Using Silsesquioxane-Gelatin Additives for Improved Endothelial Affinity

Endothelialization of microporous YIGSR/PEG-modified polyurethaneurea

Endothelium Regeneration on Luminal Surface of Polyurethane Vascular Scaffold Modified with Diamine and Covalently Grafted with Gelatin.

Antimicrobial Surfaces Grafted Random Copolymers With Redv Peptide Beneficial For Endothelialization

Growth of endothelial cells on the surface of PEO modified poly(carbonate)urethanes containing grafted GRGDSP-peptides

Surface modification of polyurethane for promotion of cell adhesion and growth 1: Surface photo-grafting with N,N-dimethylaminoethyl methacrylate and cytocompatibility of the modified surface

Antimicrobial Surfaces Grafted Random Copolymers with REDV Peptide Beneficial for Endothelialization.

Development of a YIGSR-peptide-modified polyurethaneurea to enhance endothelialization

Surface tailoring for selective endothelialization and platelet inhibition via a combination of SI-ATRP and click chemistry using Cys-Ala-Gly-peptide.

DIBLOCK COMB-LIKE COPOLYMER MODIFIED SURFACE FOR SELECTIVE ADHESION OF VASCULAR ENDOTHELIAL CELLS

Surface Modification of Multiple Bioactive Peptides to Improve Endothelialization of Vascular Grafts

Surface chemical modification of poly(dimethylsiloxane) for the enhanced adhesion and proliferation of mesenchymal stem cells.

A novel strategy to graft RGD peptide on biomaterials surfaces for endothelization of small-diamater vascular grafts and tissue engineering blood vessel

Quantitative Grafting of Peptide Onto the Nontoxic Biodegradable Waterborne Polyurethanes to Fabricate Peptide Modified Scaffold for Soft Tissue Engineering

Immobilization Via Polydopamine of Dual Growth Factors on Polyetheretherketone: Improvement of Cell Adhesion, Proliferation, and Osteo-Differentiation

Chitosan Microsphere Scaffold Tethered with RGD-Conjugated Poly(methacrylic Acid) Brushes As Effective Carriers for the Endothelial Cells